News

Pfizer raises 2025 profit forecast as cost-cutting program gains traction
Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...
Pfizer Lifts Profit View as Cuts Offset Flat Sales Outlook
Pfizer Inc. raised its profit forecast for the year, with the drugmaker’s ongoing cost cuts helping to make up for a lack of ...
GlobalData on MSN4d
Pfizer shares rise 3% after upping profit forecast for 2025
Pfizer bucked the trend of a tepid big pharma Q2 window, raising its full-year profit forecast on the back of strong sales ...
Pfizer Q2 Results: Pharma major's sales jump to $14.65 billion; firm raises profit forecast for 2025 over cost cuts
Pharmaceutical major recorded a revenue jump to $14.65 billion, exceeding the market expectations. The company also raised ...
Pfizer lifts annual profit outlook as Q2 results come ahead, shares gain
Pfizer said the revised profit outlook reflects strong results in the first half of the year, improved cost efficiency, a ...
Stocks to Watch Recap: Palantir, Coinbase, Gartner, Pfizer
Shares in the data-software company were up 7.8% Tuesday after it posted higher quarterly results and [boosted its annual ...
Chicago Tribune4y
Pfizer reports a profit as vaccines begin to roll out, expects to make ...
Pfizer, the first company to get U.S. emergency use authorization for a COVID-19 vaccine, swung to a small profit in the fourth quarter as it started shipping vaccines globally. The drugmaker ...
New York Post3y
Pfizer Q1 profit, revenue soar on COVID-19 vaccine sales
Pfizer’s stock hit an all-time high price of $61.71 on Dec. 20. But that price has fallen 18% so far this year, a steeper drop than the roughly 13% decline of the Standard & Poor’s 500 index.